The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
An open-label, first-in-human, dose escalation study of a novel CD3-CD123 bispecific T-cell engager administered as a single agent by intravenous infusion in patients with relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high risk myelodysplastic syndrome.
 
Nicolas Boissel
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Pfizer
Consulting or Advisory Role - Amgen; Novartis; Pfizer; SERVIER
Research Funding - Amgen; Novartis
 
Stéphane de Botton
Consulting or Advisory Role - Agios; Celgene; Novartis; Pfizer; Pierre Fabre; SERVIER
Research Funding - Agios; Celgene
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Pierre Fabre; Sanofi
 
Xavier G. Thomas
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Pfizer; Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Sanofi
 
Ercole Rao
Employment - Sanofi
 
Hélène Bonnevaux
Employment - Sanofi
 
Chantal Rubin-Carrez
Employment - Sanofi
 
Stéphane Guerif
Employment - Sanofi
 
Eric Beys
Employment - Sanofi
 
Alice Gosselin
Employment - Sanofi
 
Anne-Laure Bauchet
Employment - Sanofi
 
Valery Novikov
Employment - Sanofi
 
Elma Fernandes
Employment - Sanofi
 
Dmitri Wiederschain
Employment - Sanofi
 
Emanuel A. Palatinsky
Employment - Sanofi
 
Karl Hsu
No Relationships to Disclose
 
Paula Goodman Fraenkel
Employment - Sanofi
Stock and Other Ownership Interests - ReviveMed (I)